Literature DB >> 28890988

The changing landscape of dermatology practice: melanoma and pump-probe laser microscopy.

Charles J Puza1, Paul J Mosca2.   

Abstract

To present current melanoma diagnosis, staging, prognosis, and treatment algorithms and how recent advances in laser pump-probe microscopy will fill in the gaps in our clinical understanding. Expert opinion and significantly cited articles identified in SCOPUS were used in conjunction with a pubmed database search on Melanoma practice guidelines from the last 10 years. Significant advances in melanoma treatment have been made over the last decade. However, proper treatment algorithm and prognostic information per melanoma stage remain controversial. The next step for providers will involve the identification of patient population(s) that can benefit from recent advances. One method of identifying potential patients is through new laser imaging techniques. Pump-probe laser microscopy has been shown to correctly identify nevi from melanoma and furthermore stratify melanoma by aggressiveness. The recent development of effective adjuvant therapies for melanoma is promising and should be utilized on appropriate patient populations that can potentially be identified using pump-probe laser microscopy.

Entities:  

Keywords:  Dermatology; Laser pump-probe microscopy; Melanoma; Microscopy; Oncology

Mesh:

Year:  2017        PMID: 28890988     DOI: 10.1007/s10103-017-2319-2

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  43 in total

1.  Improved overall survival in melanoma with combined dabrafenib and trametinib.

Authors:  Caroline Robert; Boguslawa Karaszewska; Jacob Schachter; Piotr Rutkowski; Andrzej Mackiewicz; Daniil Stroiakovski; Michael Lichinitser; Reinhard Dummer; Florent Grange; Laurent Mortier; Vanna Chiarion-Sileni; Kamil Drucis; Ivana Krajsova; Axel Hauschild; Paul Lorigan; Pascal Wolter; Georgina V Long; Keith Flaherty; Paul Nathan; Antoni Ribas; Anne-Marie Martin; Peng Sun; Wendy Crist; Jeff Legos; Stephen D Rubin; Shonda M Little; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

Review 2.  Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.

Authors:  Donald L Morton
Journal:  Clin Exp Metastasis       Date:  2012-06-24       Impact factor: 5.150

3.  ASCO 2015 update on melanoma.

Authors:  William E Carson
Journal:  Surg Oncol       Date:  2015-10-26       Impact factor: 3.279

Review 4.  Therapy for metastatic melanoma: the past, present, and future.

Authors:  Laura Finn; Svetomir N Markovic; Richard W Joseph
Journal:  BMC Med       Date:  2012-03-02       Impact factor: 8.775

Review 5.  Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers.

Authors:  Claud Grigg; Zoë Blake; Robyn Gartrell; Adrian Sacher; Bret Taback; Yvonne Saenger
Journal:  Semin Oncol       Date:  2016-10-27       Impact factor: 4.929

Review 6.  Staging and prognosis of cutaneous melanoma.

Authors:  Paxton V Dickson; Jeffrey E Gershenwald
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

7.  Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

Authors:  Jeffrey A Sosman; Kevin B Kim; Lynn Schuchter; Rene Gonzalez; Anna C Pavlick; Jeffrey S Weber; Grant A McArthur; Thomas E Hutson; Stergios J Moschos; Keith T Flaherty; Peter Hersey; Richard Kefford; Donald Lawrence; Igor Puzanov; Karl D Lewis; Ravi K Amaravadi; Bartosz Chmielowski; H Jeffrey Lawrence; Yu Shyr; Fei Ye; Jiang Li; Keith B Nolop; Richard J Lee; Andrew K Joe; Antoni Ribas
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

8.  BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells.

Authors:  Elisa Sala; Luca Mologni; Silvia Truffa; Carlo Gaetano; Gideon E Bollag; Carlo Gambacorti-Passerini
Journal:  Mol Cancer Res       Date:  2008-05-05       Impact factor: 5.852

9.  Imaging microscopic pigment chemistry in conjunctival melanocytic lesions using pump-probe laser microscopy.

Authors:  Jesse W Wilson; Lejla Vajzovic; Francisco E Robles; Thomas J Cummings; Prithvi Mruthyunjaya; Warren S Warren
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-21       Impact factor: 4.799

10.  Label-Free Imaging of Female Genital Tract Melanocytic Lesions With Pump-Probe Microscopy: A Promising Diagnostic Tool.

Authors:  Francisco E Robles; Sanghamitra Deb; Martin C Fischer; Warren S Warren; Maria Angelica Selim
Journal:  J Low Genit Tract Dis       Date:  2017-04       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.